Tandem Diabetes Care: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Tandem Diabetes Care (NASDAQ:TNDM) reported Q4 earnings with an EPS of $-0.27, missing estimates by 8.0% and a revenue decrease of $23.71 million from the previous year. This follows a pattern of missed EPS estimates in previous quarters, with a notable 14.37% share price drop after last quarter's earnings miss.
February 21, 2024 | 9:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Tandem Diabetes Care reported a Q4 EPS of $-0.27, missing estimates by 8.0%, and a significant year-over-year revenue decrease.
Tandem Diabetes Care's Q4 earnings miss and the pattern of missing EPS estimates in previous quarters, combined with a significant revenue decrease from the previous year, are likely to negatively impact investor confidence and the stock price in the short term. Historical data shows a 14.37% drop in share price following the last quarter's earnings miss, indicating a potential for a similar reaction.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100